Characteristics of multidrug-resistant Mycobacterium tuberculosis in Taiwan: A population-based study

被引:10
|
作者
Chang, Chia-Wei [1 ]
Wu, Mei-Hua [1 ]
Chuang, Pei-Chun [1 ]
Jou, Ruwen [1 ]
机构
[1] Ctr Dis Control, Reference Lab Mycobacteriol, Res & Diagnost Ctr, Dept Hlth, Taipei 115, Taiwan
关键词
Multidrug resistance; Genotype; Mycobacterium tuberculosis; Taiwan; DRUG-RESISTANT; MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; BEIJING GENOTYPE; DURATION; FAMILY; AGE;
D O I
10.1016/j.meegid.2011.01.021
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A population-based study was performed to characterize the genotype and drug-resistant patterns of multidrug-resistant tuberculosis (MDR-TB) in Taiwan. From 2007 to 2008, we analyzed 494 MDR Mycobacterium tuberculosis complex isolates using spacer oligonucleotide typing and drug susceptibility testing. The majority of cases occurred in the age groups of 45-54 (24.3%) and >= 65 (23.1%). Of the 494 MDR isolates, 25.1% were resistant to ethambutol, 15.6% were resistant to streptomycin, 27.1% were resistant to all four first-line anti-tuberculosis drugs, 28.9% were resistant to ofloxacin, and 8.7% were extensively drug-resistant (XDR). Compared with the SpolDB4, 86 spoligotypes were identified in 492 isolates. We observed 427 (86.8%) isolates belonging to 49 known spoligotypes and 65 isolates (13.2%) in 37 undesignated spoligotypes. Beijing lineages (50.0%) were the predominant genotype, followed by Haarlem (18.2%) and East-African-Indian (EAI) (5.7%). Geographically, Beijing lineages were predominant in all regions, whereas Haarlem lineages were predominant only in the east (28.1%) and EAI (11.3%) only in the south. Beijing lineages are statistically associated with MDR in younger age groups and eastern Taiwan. Furthermore, we found that Beijing ST1 (46.1%), Haarlem3 ST50 (7.1%) and ST742 (4.7%), and EAI2_MANILA ST19 (3.9%) were the prevalent groups. Thus, continuous surveillance with more thorough genotyping and epidemiological investigation is crucial for the prevention of further dissemination, the determination of the temporal and spatial trends of multi-drug resistance, and the emergence of XDR-TB in Taiwan. (c) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:633 / 639
页数:7
相关论文
共 50 条
  • [41] Hospital transmission of multidrug-resistant Mycobacterium tuberculosis in Rosario, Argentina
    Aita, J
    Barrera, L
    Reniero, A
    Lopez, B
    Biglione, J
    Weisburd, G
    Rajmil, JC
    Largacha, C
    Ritacco, V
    MEDICINA-BUENOS AIRES, 1996, 56 (01) : 48 - 50
  • [42] Outbreak of multidrug-resistant tuberculosis in an aboriginal family in eastern Taiwan
    Tang, Tao Qian
    Fu, Ser-Chen
    Chen, Ying-Huei
    Chien, Shun-Tien
    Lee, Jen-Jyh
    Lin, Chih-Bin
    TZU CHI MEDICAL JOURNAL, 2016, 28 (01): : 29 - 32
  • [43] Antibacterial Components of Levisticum officinale Koch against Multidrug-resistant Mycobacterium tuberculosis
    Monsefesfahani, Hamidreza
    Farimani, Mandi Moridi
    Ebrahimi, Samad Nejad
    Jung, Jee Hyung
    Aliahmadi, Atousa
    Abbas-Mohammadi, Mahdi
    Skropetas, Danielle
    Kazemian, Hossein
    Feizabadi, Mohammadmehdi
    Miran, Mansour
    PHARMACEUTICAL SCIENCES, 2020, 26 (04) : 441 - 447
  • [44] First genetic characterisation of multidrug-resistant Mycobacterium tuberculosis isolates from Algeria
    Bouziane, Feriel
    Allem, Rachida
    Sebaihia, Mohammed
    Kumanski, Sylvain
    Mougari, Faiza
    Sougakoff, Wladimir
    Raskine, Laurent
    Yala, Djamel
    Cambau, Emmanuelle
    Aubry, Alexandra
    Bonnet, Isabelle
    Benmansour, Hana
    Jaffre, Jeremy
    Jarlier, Vincent
    Lecorche, Emmanuel
    Morel, Florence
    Robert, Jerome
    Veziris, Nicolas
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2019, 19 : 301 - 307
  • [45] The molecular characteristic of multidrug-resistant strains of Mycobacterium tuberculosis isolated in Northwestern Russia
    A. A. Vyazovaya
    I. V. Mokrousov
    V. Yu. Zhuravlev
    N. S. Solovieva
    T. F. Otten
    O. A. Manicheva
    B. I. Vishnevsky
    O. V. Narvskaya
    Molecular Genetics, Microbiology and Virology, 2016, 31 : 36 - 39
  • [46] Linezolid resistance among multidrug-resistant Mycobacterium tuberculosis clinical isolates in Iran
    Khosravi, Azar Dokht
    Tabandeh, Mohammad Reza
    Shahi, Fatemeh
    Salmanzadeh, Shokrollah
    ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, 2021, 68 (03) : 203 - 207
  • [47] Highly successful treatment outcome of multidrug-resistant and genetic diversity of multidrug-resistant Mycobacterium tuberculosis strains in Rwanda
    Muvunyi, Claude Mambo
    Ngabonziza, Jean Claude Semuto
    Uwimana, Innocent
    Harelimana, Jean De Dieu
    Mucyo, Yves
    Sebatunzi, Osee Rurambya
    Muvunyi, Thierry Zawadi
    Seruyange, Eric
    Masaisa, Florence
    Mazarati, Jean Baptiste
    Gasana, Michel
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2019, 24 (07) : 879 - 887
  • [48] Genetic Diversity and Transmission of Multidrug-Resistant Mycobacterium tuberculosis strains in Lusaka, Zambia
    Chizimu, Joseph Yamweka
    Solo, Eddie Samuneti
    Bwalya, Precious
    Kapalamula, Thoko Flav
    Akapelwa, Mwangala Lonah
    Lungu, Patrick
    Shrestha, Dipti
    Fukushima, Yukari
    Mukonka, Victor
    Thapa, Jeewan
    Nakajima, Chie
    Suzuki, Yasuhiko
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 114 : 142 - 150
  • [49] Human multidrug-resistant Mycobacterium bovis infection in Mexico
    Vazquez-Chacon, Carlos A.
    Martinez-Guarneros, Armando
    Couvin, David
    Gonzalez-y-Merchand, Jorge A.
    Rivera-Gutierrez, Sandra
    Escobar-Gutierrez, Alejandro
    De-la-Cruz Lopez, Juan J.
    Gomez-Bustamante, Adriana
    Gonzalez-Macal, Gabriela A.
    Goncalves Rossi, Livia Maria
    Muniz-Salazar, Raquel
    Rastogi, Nalin
    Vaughan, Gilberto
    TUBERCULOSIS, 2015, 95 (06) : 802 - 809
  • [50] Multidrug-resistant tuberculosis
    Wulandari, Dika Apriliana
    Hartati, Yeni Wahyuni
    Ibrahim, Abdullahi Umar
    Pitaloka, Dian Ayu Eka
    Irkham
    CLINICA CHIMICA ACTA, 2024, 559